Venture Capital Access Online | The eMarketplace for the Venture Capital Industry


Bookmark and Share   


Contact Us






Venture Capital Database 2018 Now Available!

Bjond Closes $3.25 Million in Series A Financing

Bjond's flagship software, BjondHealth, will optimize care for everyone, from chronically ill to worried well

COLUMBUS, Ohio, April 4, 2014-- Today Bjond, Inc. announced that it closed $3.25 million in Series A financing. Draper Triangle Ventures led the round, joined by co-investors TriStar Technology Ventures and Hopen Life Science Ventures. Bjond's flagship software, BjondHealth, uses workflow automation, decision support, and behavioral economics to transform care management and drive behavior change among chronically ill and worried well people. Bjond has attracted a large payer and provider following and will use its Series A funds to accelerate implementing BjondHealth's latest version.

"We're very excited about Bjond and believe its impact on wellness will be profound," said Will Indest, Managing Director, Draper Triangle. "With BjondHealth, healthcare payers and providers can increase productivity in care management while reducing medical costs and improving patients' lives."

"Healthcare faces mounting pressure to provide higher quality care at significantly lower cost. BjondHealth enables payers and providers to deliver efficient care and help chronically ill patients stay healthy while extracting value from legacy care management systems," said David Blauer, Bjond CEO. "Empowering patients to engage in their health improves outcomes and helps control costs; this is priority one for healthcare leaders."

About Bjond, Inc.

Bjond, Inc., with offices in Boston and Columbus, provides transformative workflow automation, decision support, and behavior change tools. Its flagship application, BjondHealth, fuels a continuous cycle of data-driven care that profoundly improves patients' lives. For more information, visit

About Draper Triangle Ventures

Draper Triangle Ventures is a premier source of funding for early stage high-technology companies in the Midwest. As the Midwest-based partner of Draper Fisher Jurvetson, Draper Triangle offers entrepreneurs a host of benefits unrivaled in the industry. For more information, visit

About TriStar Ventures

TriStar Technology Ventures is an early stage venture firm that invests in companies in healthcare innovation: life sciences, medical technologies, healthcare IT and healthcare services. TriStar's mission is to identify, create and grow early stage, transformative healthcare companies. For more information, visit

About Hopen Life Science Ventures

Hopen Life Science Ventures invests in promising early-to mid-stage life science and healthcare companies. Hopen manages over $65 million between its two funds. The firm is actively making new investments via Hopen Life Science Fund II. For more information visit

News Index

Venture Capital Database 



Latest VC News
VC News Archive
News Search
RSS News Feed

List Your Firm


Venture Capital Database

VCPro Database
Download Trial
Buy Now

Business Plan Tools

Free Business Plan Template
Business Plan Tools



Copyright © 1998-2018 Access InterComm  All rights reserved. 
Site Map | Privacy Statement | Legal Notice & Disclaimer